Advertisement
Screener

AMERICAN SHARED HOSPITAL SERVICES (AMS) Increase (Decrease) in Due to Related Parties

2.8 / 5 stars · 68/120 Roast Me

AMERICAN SHARED HOSPITAL SERVICES Increase (Decrease) in Due to Related Parties

AMERICAN SHARED HOSPITAL SERVICES (AMS) reported Increase (Decrease) in Due to Related Parties of $669.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInDueToRelatedParties · last filed 2026-08-13

  • AMERICAN SHARED HOSPITAL SERVICES increase (decrease) in due to related parties for the quarter ending 2026-06-30 was $350.00K.
  • AMERICAN SHARED HOSPITAL SERVICES increase (decrease) in due to related parties for the quarter ending 2026-03-31 was $319.00K, a 440.68% increase year-over-year.
  • AMERICAN SHARED HOSPITAL SERVICES increase (decrease) in due to related parties for the quarter ending 2025-12-31 was -$1.71M, a 173.30% decline year-over-year.
  • AMERICAN SHARED HOSPITAL SERVICES increase (decrease) in due to related parties for the quarter ending 2025-09-30 was $2.61M.
  • AMERICAN SHARED HOSPITAL SERVICES increase (decrease) in due to related parties for fiscal 2025 was $207.00K, a 36.11% decline from fiscal 2024.
  • AMERICAN SHARED HOSPITAL SERVICES increase (decrease) in due to related parties for fiscal 2024 was $324.00K.
  • AMERICAN SHARED HOSPITAL SERVICES increase (decrease) in due to related parties for fiscal 2023 was -$491.00K.
  • AMERICAN SHARED HOSPITAL SERVICES increase (decrease) in due to related parties for fiscal 2022 was -$845.00K, a 209.03% decline from fiscal 2021.
Period endIncrease (Decrease) in Due to Related Parties 3 monthIncrease (Decrease) in Due to Related Parties 6 monthIncrease (Decrease) in Due to Related Parties 9 monthIncrease (Decrease) in Due to Related Parties 12 month
2026-06-30$350.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13
$669.00K
10-Q · filed 2026-08-13
-$1.04M
derived: sum of 3 quarters · filed 2026-08-13
$1.57M
derived: sum of 4 quarters · filed 2026-08-13
2026-03-31$319.00K
10-Q · filed 2026-05-14
-$1.39M
derived: sum of 2 quarters · filed 2026-05-14
$1.22M
derived: sum of 3 quarters · filed 2026-05-14
$467.00K
derived: sum of 4 quarters · filed 2026-08-13
2025-12-31-$1.71M
derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-31
$905.00K
derived: sum of 2 quarters · filed 2026-03-31
$148.00K
derived: sum of 3 quarters · filed 2026-08-13
$207.00K
10-K · filed 2026-03-31
2025-09-30$2.61M
derived: 10-Q/A 9 month − 10-Q 6 month · filed 2026-01-16
$1.86M
derived: sum of 2 quarters · filed 2026-08-13
$1.92M
10-Q/A · filed 2026-01-16
$4.25M
derived: sum of 4 quarters · filed 2026-08-13
2025-06-30-$757.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13
-$698.00K
10-Q · filed 2026-08-13
$1.63M
derived: sum of 3 quarters · filed 2026-08-13
$1.50M
derived: sum of 4 quarters · filed 2026-08-13
2025-03-31$59.00K
10-Q · filed 2026-05-14
$2.39M
derived: sum of 2 quarters · filed 2026-05-14
$2.26M
derived: sum of 3 quarters · filed 2026-05-14
$2.28M
derived: sum of 4 quarters · filed 2026-05-14
2024-12-31$2.33M
derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-31
$2.20M
derived: sum of 2 quarters · filed 2026-03-31
$2.22M
derived: sum of 3 quarters · filed 2026-03-31
$324.00K
10-K · filed 2026-03-31
2024-09-30-$129.00K
derived: 10-Q/A 9 month − 10-Q 6 month · filed 2026-01-16
-$108.00K
derived: sum of 2 quarters · filed 2026-01-16
-$2.01M
10-Q/A · filed 2026-01-16
-$4.79M
derived: sum of 4 quarters · filed 2026-01-16
2024-06-30$21.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13
-$1.88M
10-Q · filed 2025-08-13
-$4.66M
derived: sum of 3 quarters · filed 2025-08-13
-$3.02M
derived: sum of 4 quarters · filed 2025-08-13
2024-03-31-$1.90M
10-Q · filed 2025-05-15
-$4.68M
derived: sum of 2 quarters · filed 2025-05-15
-$3.04M
derived: sum of 3 quarters · filed 2025-05-15
-$2.32M
derived: sum of 4 quarters · filed 2025-05-15
2023-12-31-$2.78M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-04
-$1.15M
derived: sum of 2 quarters · filed 2025-04-04
-$425.00K
derived: sum of 3 quarters · filed 2025-04-04
-$491.00K
10-K · filed 2025-04-04
2023-09-30$1.64M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14
$2.36M
derived: sum of 2 quarters · filed 2024-11-14
$2.29M
10-Q · filed 2024-11-14
$2.37M
derived: sum of 4 quarters · filed 2024-11-14
2023-06-30$722.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14
$656.00K
10-Q · filed 2024-08-14
$735.00K
derived: sum of 3 quarters · filed 2024-08-14
$603.00K
derived: sum of 4 quarters · filed 2024-08-14
2023-03-31-$66.00K
10-Q · filed 2024-05-15
$13.00K
derived: sum of 2 quarters · filed 2024-05-15
-$119.00K
derived: sum of 3 quarters · filed 2024-05-15
-$106.00K
derived: sum of 4 quarters · filed 2024-05-15
2022-12-31$79.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01
-$53.00K
derived: sum of 2 quarters · filed 2024-04-01
-$40.00K
derived: sum of 3 quarters · filed 2024-04-01
-$845.00K
10-K · filed 2024-04-01
2022-09-30-$132.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14
-$119.00K
derived: sum of 2 quarters · filed 2023-11-14
-$924.00K
10-Q · filed 2023-11-14
-$634.00K
derived: sum of 4 quarters · filed 2023-11-14
2022-06-30$13.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14
-$792.00K
10-Q · filed 2023-08-14
-$502.00K
derived: sum of 3 quarters · filed 2023-08-14
-$687.00K
derived: sum of 4 quarters · filed 2023-08-14
2022-03-31-$805.00K
10-Q · filed 2023-05-12
-$515.00K
derived: sum of 2 quarters · filed 2023-05-12
-$700.00K
derived: sum of 3 quarters · filed 2023-05-12
2021-12-31$290.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31
$105.00K
derived: sum of 2 quarters · filed 2023-03-31
$775.00K
10-K · filed 2023-03-31
2021-09-30-$185.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10
$485.00K
10-Q · filed 2022-11-10
2021-06-30$670.00K
10-Q · filed 2022-08-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
Advanced Biomed Inc. (ADVB)$0.009B
Aclarion, Inc. (ACON)United States$0.008B
BioNexus Gene Lab Corp (BGLC)$0.004B
SERA PROGNOSTICS, INC. (SERA)United States$0.062B-5.75
Freenome, Inc. (FRNM)United States$0.143B
EXAGEN INC. (XGN)United States$0.212B-5.95
BIODESIX INC (BDSX)United States$0.312B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45